Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.

Biotechnology

Pharmaceutical

Splisense

Splisense's headquarters in Jerusalem, Israel

Gili Hart

Ilana Bearman

Lital Friedman

Asaf Cohen

This department oversees the strategic exploration and identification of new opportunities within the organization.

Discovery Division

This department manages and supports the executive leadership in driving the organization's strategic initiatives and operational effectiveness.

Executive Operations

This department is responsible for overseeing and managing the execution of projects to ensure they meet organizational objectives.

Project Management

This department focuses on advancing knowledge and innovation through scientific investigation and analysis.

Research and Development

This department conducts studies and analyzes data to advance knowledge and inform decision-making.

Splisense

Org chart

Teams

Discovery Division

Executive Operations

Project Management

Research and Development

Research Department

Offices

Splisense

Org chart

Teams

Discovery Division

Executive Operations

Project Management

Research and Development

Research Department

Offices

Related companies